摘要
目的探讨精神分裂症稳定期应用非典型抗精神病药物治疗的成本-效果。方法采用药物经济学决策树模型分析方法,选择期望成本最小治疗方案评价非典型抗精神病药物的治疗效果。结果在1年稳定期内,使患者病情持续稳定,棕榈酸帕利哌酮注射液治疗方案与利培酮长效注射液治疗方案的费用分别为19 539.2元和17 187.6元;而对应的期望治疗成本分别为36 183.7元和35 807.4元。结论利培酮长效注射液治疗方案对精神分裂症稳定期的治疗效果更好,且花费少。
Objective To investigate the effect of schizophrenia stable period with atypical antipsychotic treatment cost.Methods Using pharmacoeconomic model of decision tree analysis method,the choice of treatment plan evaluation cost minimum expectations of atypical antipsychotics treatment effect.Results In a year of stable period, so that patients with stable disease,long-acting injection treatment scheme of palmitic acid Paley cefoperazone injection in the treatment of risperidone and plan costs were 19 539.2 yuan and 17 187.6 yuan;and the desired treatment cost corresponding respectively is 36 183.7 yuan and 35 807.4 yuan.Conclusion Risperidone long-acting injection in the treatment of schizophrenia and stable period solution treatment are better for the spirit,and it cost less.
出处
《中国药物经济学》
2015年第2期8-10,共3页
China Journal of Pharmaceutical Economics
